Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Preventive Cardiology
|
March 8, 2003
A prospective study in primary care in patients without vascular disease comparing levels of coronary risk factors in those recommended for lipid-lowering drugs based on either absolute risk or absolute risk reduction
Sud Ramachandran, Peter Croft, Richard H Neary
Metabolic Syndrome and Related Disorders
|
January 31, 2012
Significant increase in high-density lipoprotein cholesterol with fibrates is associated with low pretreatment high-density lipoprotein cholesterol: findings from an outpatient clinic setting
Sud Ramachandran, Ahmed Abbas, Sanjay Saraf, et al.
Clinical Endocrinology
|
January 9, 2021
Lessons learnt from the variation across 6741 family/general practices in England in the use of treatments for hypogonadism
Adrian H Heald, Michael Stedman, Martin Whyte, et al.
European Heart Journal
|
August 12, 2009
Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapy
Paul W X Foley, Berthold Stegemann, Kelvin Ng, et al.
Annals of Clinical Biochemistry
|
July 1, 2023
Standardising the biochemical confirmation of adult male hypogonadism; a joint position statement by the Society for Endocrinology and Association of Clinical Biochemistry and Laboratory Medicine
Channa N Jayasena, Nipun Lakshitha de Silva, Michael W O'Reilly, et al.
Clinical Endocrinology
|
July 1, 2023
Standardising the biochemical confirmation of adult male hypogonadism: A joint position statement by the Society for Endocrinology and Association of Clinical Biochemistry and Laboratory Medicine
Channa N Jayasena, Nipun L de Silva, Michael W O'Reilly, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Preventive Cardiology
|
March 8, 2003
A prospective study in primary care in patients without vascular disease comparing levels of coronary risk factors in those recommended for lipid-lowering drugs based on either absolute risk or absolute risk reduction
Sud Ramachandran, Peter Croft, Richard H Neary
Metabolic Syndrome and Related Disorders
|
January 31, 2012
Significant increase in high-density lipoprotein cholesterol with fibrates is associated with low pretreatment high-density lipoprotein cholesterol: findings from an outpatient clinic setting
Sud Ramachandran, Ahmed Abbas, Sanjay Saraf, et al.
Clinical Endocrinology
|
January 9, 2021
Lessons learnt from the variation across 6741 family/general practices in England in the use of treatments for hypogonadism
Adrian H Heald, Michael Stedman, Martin Whyte, et al.
European Heart Journal
|
August 12, 2009
Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapy
Paul W X Foley, Berthold Stegemann, Kelvin Ng, et al.
Annals of Clinical Biochemistry
|
July 1, 2023
Standardising the biochemical confirmation of adult male hypogonadism; a joint position statement by the Society for Endocrinology and Association of Clinical Biochemistry and Laboratory Medicine
Channa N Jayasena, Nipun Lakshitha de Silva, Michael W O'Reilly, et al.
Clinical Endocrinology
|
July 1, 2023
Standardising the biochemical confirmation of adult male hypogonadism: A joint position statement by the Society for Endocrinology and Association of Clinical Biochemistry and Laboratory Medicine
Channa N Jayasena, Nipun L de Silva, Michael W O'Reilly, et al.
Page
of 1